Characterizing lung interstitial and airway diseases to improve diagnosis and care
Official title: Establishment of Diagnosis and Classification System for Lung Interstitial and Airway Diseases (LIAD)
Run by Xiangya Hospital of Central South University · NCT06987266 · Data updated 2026-11-12
This multicenter study will look at how interstitial lung disease and airway disease occur together and with other conditions, then create clearer diagnostic criteria and see how these diseases behave over time.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 40 Years to 80 Years |
| Sex | All |
| Enrollment | 900 (estimated) |
| Sponsor | Xiangya Hospital of Central South University Academic / other |
| Locations | 1 site (Changsha, Hunan) |
| Status | Recruiting |
| Started | May 20, 2025 |
| Main results expected | November 30, 2028 |
| Study ends | November 30, 2028 |
| Registry record updated | August 24, 2026 |
| Trial ID | NCT06987266 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 40–80 with COPD, idiopathic pulmonary fibrosis, nonspecific interstitial pneumonia, or related conditions who have hospitalization records or outpatient diagnoses and can complete pulmonary function tests and CT imaging.
✕Probably not a fit
Patients whose disease does not involve ILD or airway disease, or who do not meet the imaging/function criteria, may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Researchers will start with a large retrospective review from 9 hospitals covering about 10,000 cases to describe how ILD and airway diseases co-occur and relate to other lung conditions. They will develop classification and diagnostic criteria based on these findings. Next, a prospective, disease-specific cohort of about 900 patients will be followed for up to 2 years to observe prognosis, identify prognostic factors, and assess comorbidity severity. The study will also examine current treatments and associated medical costs through cost-effectiveness analyses over a total 4-year period (2024–2028).
Why it matters
Potential benefit: If successful, the work could standardize how ILD and airway diseases are diagnosed and managed, potentially improving care and resource use.
How similar studies have gone: Previous studies have shown that similar approaches can reveal patterns in comorbidity and improve classification, though this specific combined ILD/airway framework is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. age between 40-80 years old; 2. inpatients with an admission diagnosis of COPD, Idiopathic pulmonary fibrosis, nonspecific interstitial pneumonia, patients with the following diagnoses were screened by chest CT (slice thickness ≤1.5 mm) during hospitalization and by in-hospital or prior pulmonary function; 3. Inpatients who meet the criteria can complete pulmonary function tests and chest HRCT examinations within one month before expected discharge (excluding hospitalized patients with stable interstitial lung disease or airway disorders); 4. among outpatients, patients with chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis, nonspecific interstitial pneumonia, COPD with pulmonary interstitial abnormalities, idiopathic pulmonary fibrosis with airway lesions, nonspecific interstitial pneumonia with airway lesions, pulmonary fibrosis with emphysema syndrome were diagnosed through chest CT (layer thickness ≤1.5mm) and lung function; 5. provide informed consent. Exclusion Criteria: 1. expected survival less than 12 months; 2. planned lung transplantation or pneumonectomy within 12 months; 3. pregnant or lactating women; 4. Has previously undergone lobectomy or received thoracic radiotherapy.
Where it's running
-
Xiangya Hospital
Changsha, Hunan, China Recruiting
Study contacts
- Study coordinator: Ruoxi He, MD
- Email: heruoxi@csu.edu.cn
- Phone: 86+18874167666
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
New breathing tests to diagnose airway disease in hospital and community settings
This study tests whether newer breathing tests can correctly diagnose COPD and airway disease as well as standard spirometry, using tests like capnography and oscillometry in hospital and community settings.
-
PNEUMO-LIBS: Using tissue imaging and AI to explore causes of chronic lung diseases
This study tests whether multi-element tissue imaging with LIBS, plus the AI tool IFF, can help doctors understand possible causes of chronic lung diseases in adults who have had a lung biopsy.
-
Functional MRI to characterize and monitor interstitial lung disease
This project tries functional MRI scans to see if they can tell different ILD types apart and track whether the disease is getting better, worse, or staying the same.
-
Tubeless (non-intubated) tracheal and carinal reconstruction
This study will test whether tubeless (non-intubated) tracheal and carinal reconstruction is as safe and gives better perioperative outcomes than conventional intubated surgery for adults with tracheal or airway disease.
-
Comparing exercise capacity and muscle oxygenation in patients with interstitial lung disease and healthy individuals
This study looks at how exercise and muscle oxygen levels differ between people with interstitial lung disease and healthy individuals to better understand the challenges ILD patients face in staying active.
-
Evaluating a test for upper extremity exercise capacity in patients with interstitial lung disease
This study is testing a new exercise test for patients with interstitial lung disease to see if it can better measure their upper body strength and endurance compared to traditional methods.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.